Sarcoma | Clinical

Unmet Needs in GIST

May 07, 2021

Brian Van Tine, MD, PhD, and Fadi Braiteh, MD, discuss unmet needs in the treatment of gastrointestinal stromal tumors (GISTs) and look to the future in terms of the evolving field.

GIST Treatments: A Multidisciplinary Approach

May 07, 2021

Experts discuss the role of multidisciplinary management for patients with gastrointestinal stromal tumors (GISTs).

Later Lines of Therapy for GIST Treatments

April 23, 2021

Implications for treating patients with gastrointestinal stromal tumors (GISTs) in the later lines of therapy after switching from 1 treatment to another.

Current Treatment Options in GIST

April 23, 2021

Brian Van Tine, MD, PhD, and Fadi Braiteh, MD, discuss the current treatment options that are available for the treatment of gastrointestinal stromal tumor (GIST).

Mutations in GIST

April 23, 2021

An overview of mutations in gastrointestinal stromal tumor (GIST) and how they can influence treatment selection.

GIST Sequencing in the Adjuvant Setting

April 23, 2021

Considerations for gastrointestinal stromal tumor (GIST) sequencing in the adjuvant setting.

Sequencing Resectable GIST

April 23, 2021

Fadi Braiteh, MD, discusses sequencing in patients with resectable and unresectable gastrointestinal stromal tumors (GISTs) and explains the impact on treatment considerations.

Approach to GIST Sequencing

April 23, 2021

Experts in the field of gastrointestinal stromal tumors (GISTs) discuss the role of sequencing therapy in the frontline and later-line settings.

Advances in Later-Lines of Therapy for GIST

April 23, 2021

Experts discuss advances in gastrointestinal stromal tumors (GIST) and dive into the evolving landscape and ongoing unmet needs.

FDA Grants Fast Track Designation to Next-Generation Anthracycline for STS Lung Metastases

March 31, 2021

The FDA has granted fast track designation to Annamycin for the treatment of soft tissue sarcoma lung metastases, according to a press release from Moleculin Biotech, Inc.